| HOME >> BIOLOGY >> TECHNOLOGY |
TROY, Mich., Nov. 11 /PRNewswire/ -- CJPS Enterprises, LLC ( http://www.CJPS-Enterprises.com ) announced that it has seen a surge in the demand of its services to leverage companies' intellectual property (IP) to create new revenues, as well as increasing the value of their intangible assets. This customized service is execution-driven, rapid and affordable.
Although CJPS Enterprises is a firm that specializes in growing companies in the healthcare industry, it works with companies in all industries (from automotive to aerospace) to assess their IP portfolio to uncover opportunities for revenues and an increase in the value of their assets.
Along with its powerful industry contacts in the medical devices industry, looking for innovations and technologies to help build up their portfolio or to enter new market segments, CJPS Enterprises is able to efficiently and rapidly marry demand with a mostly-untapped supply. They also work with corporate, academic, and clinical research institutions looking to sell or license out their IP.
"Our background is not in consulting, but in running businesses in the biotechnology, diagnostics, and medical devices markets," says Christophe Sevrain, CEO of CJPS Enterprises. "We probably have the largest and deepest network of contacts in the industry, and if you are trying to license (in or out), sell or acquire healthcare innovations, we know how to go about it and who might have an interest."
Lately, some of the largest companies in the world have called on the
firm to have their IP portfolio analyzed, and to find companies who can use
that intellectual property in fields of use outside those companies'
business focus. This has the effect of generating revenues through royalty
payments for the IP holders in markets that they would have never gotten
into, as well as creating a higher value for those intangible assets, which
may have been othe
'/>"/>
| SOURCE CJPS Enterprises, LLC Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
2. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
3. Knowledge Enterprises, Inc. and The Institute for Orthopaedics(TM) Release The 2007-2008 Orthopaedic Industry Annual Report
4. SMErobot: A new generation of robots for small and medium-sized enterprises at Automatica 2008
5. CYIG Awarded Chinas "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "Torch Plan Key High-Tech Enterprise"
6. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
7. Nu Skin Enterprises to Hold 2007 Analyst Day
8. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
9. Neogen Acquires Kane Enterprises
10. Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility
11. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |